Skip to main content
logo
Astellas Pharma Inc. (ALPMY)
OTCMKTS · Delayed Price · Currency is USD
11.48
+0.18 (1.59%)
Sep 5, 2025, 3:59 PM EDT

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2005 - 2019
Pharmaceutical
1,912.32B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
19.25%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2005 - 2019
United States
866.38B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
30.65%
Log In
Log In
Log In
Log In
Upgrade
Established Markets
485.42B
Log In
Log In
Log In
Log In
Upgrade
Established Markets Growth
16.81%
Log In
Log In
Log In
Log In
Upgrade
Japan
267.00B
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
-1.16%
Log In
Log In
Log In
Log In
Upgrade
International
203.51B
Log In
Log In
Log In
Log In
Upgrade
International Growth
27.94%
Log In
Log In
Log In
Log In
Upgrade
China
78.31B
Log In
Log In
Log In
Log In
Upgrade
China Growth
-11.52%
Log In
Log In
Log In
Log In
Upgrade
Other
11.71B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
60.49%
Log In
Log In
Log In
Log In
Upgrade